NEWS

COLLEGE OF PHARMACY PROGRAM AWARDED $34M CONTRACT RENEWAL TO TEST AND IDENTIFY INVESTIGATIONAL THERAPEUTICS THAT PREVENT AND TREAT DRUG-RESISTANT EPILEPSY

COLLEGE OF PHARMACY PROGRAM AWARDED $34M CONTRACT RENEWAL TO TEST AND IDENTIFY INVESTIGATIONAL THERAPEUTICS THAT PREVENT AND TREAT DRUG-RESISTANT EPILEPSY

The University of Utah College of Pharmacy’s Anticonvulsant Drug Development (ADD) Program has been awarded a five-year $34 million contract renewal with the NIH’s National Institute of Neurological Disorders and Stroke (NINDS) to test and identify novel...

read more
Taken during pregnancy, Topiramate, an antiepileptic drug, increases the risk of autism in children, warns the ANSM

Taken during pregnancy, Topiramate, an antiepileptic drug, increases the risk of autism in children, warns the ANSM

The risk of autistic disorders in children is increased more than two and a half times when Topiramate is consumed during pregnancy. This drug, used to treat epilepsy, also more than triples the risk of intellectual disability, a study has found. Topiramate, used to...

read more